# Lung Immune Challenge Study: Controlled Exposure to Inhaled Resiquimod (R848)

> **NCT06488118** · NA · RECRUITING · sponsor: **Akhilesh Jha** · enrollment: 36 (estimated)

## Conditions studied

- Innate Immunity
- Mucosal Immunity
- Asthma
- Viral Infection

## Interventions

- **DRUG:** R848
- **DRUG:** Saline

## Key facts

- **NCT ID:** NCT06488118
- **Lead sponsor:** Akhilesh Jha
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-05-24
- **Primary completion:** 2025-05
- **Final completion:** 2025-07
- **Target enrollment:** 36 (ESTIMATED)
- **Last updated:** 2024-07-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06488118

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06488118, "Lung Immune Challenge Study: Controlled Exposure to Inhaled Resiquimod (R848)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06488118. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*